Breast MRI for women with hereditary cancer risk

被引：26
作者：
Robson, ME [1 ]
Offit, K [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, New York, NY 10021 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 11期
关键词：
D O I：
10.1001/jama.292.11.1368
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1368 / 1370
页数：3
相关论文
共 27 条
  • [1] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
    Antoniou, A
    Pharoah, PDP
    Narod, S
    Risch, HA
    Eyfjord, JE
    Hopper, JL
    Loman, N
    Olsson, H
    Johannsson, O
    Borg, Å
    Pasini, B
    Radice, P
    Manoukian, S
    Eccles, DM
    Tang, N
    Olah, E
    Anton-Culver, H
    Warner, E
    Lubinski, J
    Gronwald, J
    Gorski, B
    Tulinius, H
    Thorlacius, S
    Eerola, H
    Nevanlinna, H
    Syrjäkoski, K
    Kallioniemi, OP
    Thompson, D
    Evans, C
    Peto, J
    Lalloo, F
    Evans, DG
    Easton, DF
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1117 - 1130
  • [2] *BLUECROSS BLUESHI, MAGN RES IM BREAST S
  • [3] Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk
    Brekelmans, CTM
    Seynaeve, C
    Bartels, CCM
    Tilanus-Linthorst, MMA
    Meijers-Heijboer, EJ
    Crepin, CMG
    van Geel, AN
    Menke, M
    Verhoog, LC
    van den Ouweland, A
    Obdeijn, IM
    Klijn, JGM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 924 - 930
  • [4] Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2
    Burke, W
    Daly, M
    Garber, J
    Botkin, J
    Kahn, MJE
    Lynch, P
    McTierman, A
    Offit, K
    Perlman, J
    Petersen, G
    Thomson, E
    Varricchio, C
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12): : 997 - 1003
  • [5] Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers
    Hartmann, LC
    Sellers, TA
    Schaid, DJ
    Frank, TS
    Soderberg, CL
    Sitta, DL
    Frost, MH
    Grant, CS
    Donohue, JH
    Woods, JE
    McDonnell, SK
    Vockley, CW
    Deffenbaugh, A
    Couch, FJ
    Jenkins, RB
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (21): : 1633 - 1637
  • [6] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff, ND
    Satagopan, JM
    Robson, ME
    Scheuer, L
    Hensley, M
    Hudis, CA
    Ellis, NA
    Boyd, J
    Borgen, PI
    Barakat, RR
    Norton, L
    Offit, K
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1609 - 1615
  • [7] Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
    King, MC
    Wieand, S
    Hale, K
    Lee, M
    Walsh, T
    Owens, K
    Tait, J
    Ford, L
    Dunn, BK
    Costantino, J
    Wickerham, L
    Wolmark, N
    Fisher, B
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2251 - 2256
  • [8] Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
    Kriege, M
    Brekelmans, CTM
    Boetes, C
    Besnard, PE
    Zonderland, HM
    Obdeijn, IM
    Manoliu, RA
    Kok, T
    Peterse, H
    Tilanus-Linthorst, MMA
    Muller, SH
    Meijer, S
    Oosterwijk, JC
    Beex, LVAM
    Tollenaar, RAEM
    de Koning, HJ
    Rutgers, EJT
    Klijn, JGM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) : 427 - 437
  • [9] KUHL CK, 2003, P AN M AM SOC CLIN, V22, P2
  • [10] Breast cancer screening with MRI - What are the data for patients at high risk?
    Liberman, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) : 497 - 500
123